ATLAS: Improved PFS With Addition of Erlotinib to ...
4. Herbst RS, O'Neill VJ, Fehrenbacher L, et al. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer. J Clin Oncol. 2007;25:4743-4750. 5. Hainsworth J, Lin M, O’Connor P, et al. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- australian public assessment report foratezolizumab
- treatment of metastatic non small cell lung cancer a
- lung cancer cnazone
- registration status pharmaceutical benefits scheme pbs
- american society of clinical oncology asco
- future science home
- pemetrexed maintenance therapy significantly improves pfs
- note the following description is taken from emerson and
- atlas improved pfs with addition of erlotinib to
- pharmacology—chemotherapy and supportive care
Related searches
- loan calculator with schedule of payments
- with both of you
- sig figs with addition and subtraction
- addition of binary numbers
- addition of binary numbers calculator
- analytical addition of vector calculator
- speaking with you or speaking to you
- elderly with severe dementia wants to die
- diameter of circle with circumference of 9
- addition of determinants
- addition of binary number
- addition worksheets up to 10